Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases

• 收藏
• 分享

专利权人:

DAEWOONG PHARMACEUTICAL CO. LTD.

发明人:

LEE SANG-HO,LEE JONG-WOOK,LIM TAEK-JOO,KOH EUN-JI

申请号：

NZ62500412

公开号：

NZ625004A

申请日:

2012.11.28

申请国别(地区):

NZ

年份:

2015

代理人:

摘要：

Provided is the use of a combination of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({ 2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl} methyl)-4-methyl-1,3-oxazolidin-2-one (anacetrapib) and a calcium channel blocker or a fibrate for the prevention or treatment of hypertriglyceridemia or hypertriglyceridemia-associated diseases. A preferred calcium channel blocker is amlodipine. A preferred fibrate is fenofibrate.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/